Back to Agenda
Session 10 Track 3: KOL Engagement Strategies: Best Practices in External Engagement
Session Chair(s)
Richard Swank, PhD
Founder
Scientific Engagement LLC, United States
Field Medical teams are expected to engage external stakeholders to help companies understand and shape clinical understanding and decision making. Expectations of MSL impact shift with lifecycle management changes, from developing opinion leader relationships prior to approval, to managing deeper local HCP engagement in the years post-launch. This session will delve into bast practices in translating strategy into actionable field-medical tactics, emerging approaches in using technology and tools, and improving OL management with an aim of sharing practical tips.
Learning Objective : - Identify and prioritize KOLs and design engagement activities that align with strategic objectives and product lifecycle stages, ensuring interactions are focused, relevant, and impactful
- Discuss best practices in aligning field medical teams to understand and translate strategy into meaningful opinion leader engagement using advanced technology and tools
- Identify how field medical feedback can inform and influence subsequent field medical strategy
Speaker(s)
Speaker
Joanna Gonsalves, PhD
Amgen, United States
Executive Director, Field Medical Excellence
Speaker
Vanessa A. Johnson, MS
Gilead Sciences, United States
Executive Director, Head of Global Medical Excellence
Speaker
Sunil Mehta, PharmD
Annexon Biosciences, United States
Senior Vice President, Medical Affairs
Have an account?